![James Schoeneck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Schoeneck
Vorsitzender bei
KYNTRA BIO, INC.
Vermögen: 289 330 $ am 31.05.2026
Profil
James A. Schoeneck ist ein Geschäftsmann, der bereits an der Spitze von 5 verschiedenen Unternehmen stand. Gegenwärtig hat Herr Schoeneck die Position des Vorsitzenden von FibroGen, Inc. inne. Er ist auch im Vorstand von Calidi Biotherapeutics, Inc. In seiner bisherigen Laufbahn hatte James A. Schoeneck die Position des Chief Executive Officer bei BrainCells, Inc. inne, die des President, Chief Executive Officer & Director bei Assertio Therapeutics, Inc. sowie die des Chief Executive Officer bei ActivX Biosciences, Inc, President, Chief Executive & Operating Officer bei Prometheus Laboratories, Inc, Vice President & General Manager-Immunology bei Centocor, Inc, Principal bei KYORIN Pharmaceutical Co., Ltd. und Director-Marketing & Product Group bei Rhone-Poulenc Rorer, Inc. James A. Schoeneck erwarb einen Bachelor-Abschluss an der Jacksonville State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KYNTRA BIO, INC. 0,98 % | 12.06.2026 | 39.666 ( 0,98 % ) | 273 695 $ | 31.05.2026 |
| 17.04.2026 | 84.514 ( 2,36 % ) | 15 635 $ | 31.05.2026 |
Aktive Positionen von James Schoeneck
| Unternehmen | Position | Beginn |
|---|---|---|
| KYNTRA BIO, INC. | Vorsitzender | 06.01.2020 |
| CALIDI BIOTHERAPEUTICS, INC. | Vorsitzender | 01.04.2025 |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 22.07.2025 |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Direktor/Vorstandsmitglied | 01.07.2020 |
Ehemalige bekannte Positionen von James Schoeneck
| Unternehmen | Position | Ende |
|---|---|---|
| ANAPTYSBIO, INC. | Direktor/Vorstandsmitglied | 19.03.2018 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorstandsvorsitzender | 28.03.2017 |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Vorstandsvorsitzender | 01.01.2011 |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Vorstandsvorsitzender | 01.12.2004 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Vorstandsvorsitzender | 01.01.2003 |
Ausbildung von James Schoeneck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
KYORIN Pharmaceutical Co. Ltd. (old)
 KYORIN Pharmaceutical Co. Ltd. (old) Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Jacksonville State University
 Jacksonville State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Calidi Biotherapeutics, Inc.
 Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
